1513 Hanson Road (413) 545-7481
Brattleboro, VT 05301-9227 jezeber@gmail.com
Education:
·
University of
Michigan Doctor of Philosophy (2004): Health
Services Organization & Policy (HSOP) – Sociology cognate
·
University of
Washington Masters
of Health Administration (1998)
·
Post-graduate Training:
·
University of Texas Health Science Center, San Antonio – Multi-disciplinary Clinical Research Scholars Training Program (K12)
awardee (Fall 2006-Fall 2008).
·
Veterans Affairs Health Services Research & Development (HSRD),
Summary of Professional Experience, Research
Interests, and Academic Goals:
Following a successful and rewarding past two decades of experience conducting health services research while helping develop research centers and mentoring numerous junior investigators, I recently committed to a new professional trajectory as a full-time academic faculty member. Here I look forward to sharing my research and administrative expertise with new colleagues and students at Umass Amherst, to contribute knowledge and enthusiasm in creating further innovative work in public health policy. As I develop a teaching portfolio and new institutional service, I continue to devote substaintial attention to research interests honed over 20 plus years in this field. My primary objectives have focused on three major, frequently overlapping topics: 1) health outcomes for patients with serious mental illness (schizophrenia, bipolar disorder, PTSD, depression), including medical comorbidities; 2) patient decisions surrounding medication and treatment adherence, along with the potential clinical and financial ramifications; 3) understanding and reducing ethnic, gender, access or other disparities in access to care and outcomes. A recent new emphasis area has explored implementation of innovative “no-touch” hospital technologies, including my VA R01 on portable ultraviolet ray devices, and currently a funded study utlizing copper-infused room surfaces to reduce serious infections. I have gained a national and international reputation in these areas, including invited talks and conference presentations, plus several highly cited publications, with my studies on pharmacy copayments highlighting a VA report concerning its policy effects and later a Washington Post lead article featured my work on ethnic disparities in psychiatric diagnosis, followed by an invitation to speak at a Congressional Black Caucus event. I have served on two expert panels on medication adherence, including ongoing work with an international organization, contributed effort to journal editorial boards as an associate editor, along with a stint as guest journal editor for a special ethnicity issue of Depression Research & Treatment. From collaborative work across the VA and academic partnerships, I have also accumulated significant experience on projects pertaining to understanding patient treatment preferences, enhanced implementation of the chronic care model or patient-centered medical home principles, cost-effectiveness analysis, and a grwoing portfolo in the topic of infectious disease prevention. At this stage of my professional development, I wish to translate this diverse, lengthy expeirnce with mentoring or consulting with academic faculty in health policy into a more active teaching role at the undergraduate and graduate levels.
Professional Experience:
University of Massachusetts at Amherst – Amherst, MA (September 2018 through AY 2022;
adjunct appt thereafter): Associate Professor, School of Public Health &
Health Sciences - Department Health Promotion & Policy; Program Director,
Health Policy & Management. Responsible for teaching undergraduate and
graduate courses in health administration and related fields, developing health
services research within the department, establishing collaborations with Umass
faculty and extrenal researchers, and helping run one of the two central
programs. Also serving on departmental personnel committee, advisory board for
UMass Health policy Research Laboratory, and other school and department roles.
Central Texas Veterans Health Care
System – Temple, TX (September 2010 to
present): Investigator. Continuing as a part-time funded researcher in
addiiotn to establshing collaborations at the Leeds VA, fosucing on projects
pertaining to infectious disease, mental health, and related medical
comorbidities.
Baylor Scott & White Healthcare: Center for Applied Health Research (CAHR)
and Central Texas Veterans Affairs – Temple, TX (September 2010 to 2018):
[promoted to Senior Investigator (August 2017), CAHR & Co-Director
Health Services Outcomes Core / VA Investigator. Recruited to help start a
new applied health research and outcomes center at Baylor Scott & White, in
joint effort with the Central Texas VA. Cross-divisional center devoted to
translational and outcomes research for patients for chronic medical and psychiatric
conditions, mentoring and professional development, and collaboration across
Health Care Systems Research Network members.
Veterans Evidence-Based Research,
Dissemination, and Implementation Center (VERDICT): South Texas Veterans
Affairs HSRD – San Antonio, TX (2004-2010): Investigator.
The two-year post-doctoral appointment transitioned into full position as VA
investigator, with both practical research experience and ongoing didactic
education. Projects to include dissertation follow-up efforts, other
manuscripts, collaboration with VA and university investigators, conference
presentations, and development of research grants. Ongoing collaboration is
planned on several projects, following transition to positions in
Veterans
Health Administration, Health Services Research & Development –
Texas A&M University Health Science
Center (TAMHSC), Department of Medicine: Associate Professor
(July 2011 – 2018). Occasional
lectures, course development, faculty collaboration, and mentoring of students,
residents, and fellows interested in research.
Texas A&M Rural School of Public
Health, Health Promotion and Community Health Sciences: Joint Associate Professor (February 2012 – 2018). Periodic talks
and lectures, mentoring doctoral students and clinical researchers.
University of Texas Health Science
Center at San Antonio (UTHSCSA), Department of Psychiatry: Assistant Professor
(September 2006 – 2010; adjunct through 2018). Active involvement in funded
projects, occasional lectures, interdisciplinary research, and career
development activities.
University of Texas School of Public
Health, Division of
Management, Policy and Community Health: adjunct faculty appointment as
associate professor (April 2005 – 2016). Similar to above roles; also co-developed a course in Health
Management and Policy, for MHA program (Spring-Summer 2008)
Group
Health Cooperative –
Inland
Behavioral Medical Group – Upland, CA (1995): Provider
Relations Manager. Responsible for developing a psychiatric provider
network with a growing Independent Physicians Association (PA). Involved with
marketing, credentialing and database management.
Office
Management & Administrative
PLP & Associates – Pasadena, CA
(1991-1995): Business Manager. Sole responsibility for managing
psychological group and outpatient eating disorders clinic. Budgeting, payroll,
policy development, tax preparation, financial analysis, marketing, patient
intake, and managed care coordination for $500,000 practice. Discretion given
to initiate projects and explore business options.
Wanda
B. Olsen, M.D. – Pasadena, CA (1989-1990): Office Manager. Daily
management of private psychiatry office, billing/ receivables, scheduling,
hospital coordination, patient referrals, other responsibilities.
Las
Encinas Hospital – Pasadena, CA (1987-1989): Served in
different nursing roles, including private duty and floor capacities.
Later appointed as Admissions Supervisor / Acting Director, in addition to
evening supervision.
Beverly
Enterprises – Riverside, CA (1984-1987): Numerous
departments at long-term psychiatric hospital during college vacations,
including nursing (certified nurses assistant), floor supervision, medical
records, activities, program coordination, and front office.
RESEARCH EXPERIENCE
National or
International Advisory Groups / Boards and Leadership Roles:
Publications: Google Scholar = 7,072 citations; H-index = 44; i10 index = 94; published
in 74 different journals
124)
Sesay MM, McCracken CE, Stewart C, Simon G, Penfold R, Ahmedani B, Rossom RC,
Lu CY, Beck A, Coleman KJ, Daida Y, Lynch FL, Zeber J, Copeland L,
Owen-Smith A. (2024). “Short report: Transition to International Classification
of Diseases, 10th Revision and the prevalence of autism in a cohort of
healthcare systems.” Autism, 28(5):1316-1321.
doi: 10.1177/13623613231220687. Epub 2024 Jan 19. PMID: 38240250.
123) Ranchoff BL, Jeung C, Zeber JE, Simon
GE, Ericson KM, Qian J, Geissler KH. (2024). “Transitions
in health insurance among continuously insured patients with schizophrenia”.
Schizophrenia, 10(25):1-8.
122) Ágh T, Hiligsmann M,
Borah B, Beaudart C, Turcu-Stiolica A, Manias E, Jakab I, Pednekar P, Zeber
JE, Peterson AM. (2024). “A systematic review of outcomes
for assessment of medication adherence-enhancing interventions”. Value in Health, 27(2): 133-42.
121) Elbogen EB, Zeber JE, Vogt D, Finley
EP, Perkins DF, Copeland LA. (2023).. “Financial status and well-being in recently separated
military veterans”. Military Medicine,
188:2181-88.
120) Geissler KH, Ericson KM, Simon GE, Qian J, Zeber
JE. (2023). “Differences
in insurance coverage for individuals with schizophrenia after the affordable
care act”. JAMA Psychiatry, 80(3):1-3.
119)
Zhang N, Zhou Y, Xie J, Chung J, Liu D, Zeber JE,
Yuan C, Ash A, Zhang M. (2022). “The constellation of
conditions among nursing home residents with obesity”. Journal of Multimorbidity and Comorbidity,
11:121-9
118)
Choi H, Chatterjee P, Hwang M, Huber TW, Stock EM, Lukey
JS, Zeber JE, Jinadatha C. (2022). “Can multidrug
resistant organisms become resistant to UV light following serial exposures?”.
Infection Control & Hospital
Epidemiology, 43(1):72-8.
117)
Chatterjee P, Zeber JE, Williams MD, Jinadatha C. (2021).
“Challenges in using a cold spray copper surface technology to
combat healthcare-associated infections.” [invited letter] Infection Control & Hospital
Epidemiology
116)
David N, Copeland LA, Zeber JE, Gill A, Blackburn D. (2021). “The Role of Psychological Evaluation for Bariatric Surgery
as an indicator of Health and Psychiatric Outcomes at 1, 3, and 5 years
Following Surgery”. Texas
Psychologist, 80:16-20
115) Zeber JE
& Khanna N. ”Research evidence
supporting primary care clinics in addressing the challenges presented by the
COVID pandemic”. (2021). [invited editorial] - Family Practice, 387(s1): 1-2.
114)
Geissler K, Cooper M, Zeber JE. (2021). “Association of
follow-up after an emergency department visit for mental illness with
utilization based outcomes”. Administration & Policy in Mental Health
Services, 48:718-28.
113) Cook
JM, Zeber JE, Simiola V, Rossom R, Scherrer JF, Owen-Smith AA, Ahmedani
BK, Zolfaghari K, Copeland LA.
(2020). “Comparisons between patients diagnosed with PTSD in primary versus
mental health care: data from five large health care systems across the U.S.” Journal of Clinical Psychology in Medical Settings,
28:221-8.
112) Le S, Copeland LA, Zeber
JE, Benge J, Allen L, Cho J, Liao IC, Rasmussen J. (2020). “Factors
affecting time between symptom onset and emergency department arrival in stroke
patients”. eNeurologicalSci,
21:100285.
111) Chatterjee P, Williams MD, Coppin JD,
Allton Y, Choi H, Martel JA, Zeber JE, Nelson RE, Donskey CJ, Jinadatha
C. (2020). “Effectiveness of copper-impregnated solid
surfaces on lowering microbial bio-burden levels in an acute care hospital”.
Open Forum Infectious Diseases,
8:1-5.
110)
Merced K, Imel ZE, Baldwin SA, Fischer H, Yoon T, Stewart
C, Simon G, Ahmedani BA, Beck A, Daida Y, Hubley H, Rossom R, Trinacty C,
Waitzfelder B, Zeber JE, Coleman KJ. (2020). “Provider
contributions to disparities in mental health care”. Psychiatric Services, 71(8):765-71.
109) Chin
DL, Zeber JE.
(2020). “Mental health outcomes among military service members after severe
injury in combat and TBI”. Military
Medicine, 185(6):e711-8.
108) Geissler KH, Zeber JE. (2020). “Primary
care physician referral patterns for behavioral health diagnoses”. Psyciatric Services, 71(4):389-92.
107) Pednekar
P, Ágh T, Peterson AM, Zeber JE. (2020). “Conceptual and clinical issues concerning measurement of
medication adherence” [invited letter]. Value
in Health, 23(3):407-8.
106) Owens-Smith A, Stewart
C, Sesay M, Strasser SM, Yarborough B, Ahmedani B, Miller-Matero LR, Waring SC,
Haller IV, Waitzfelder BE, Sterling SA, Campbell CI, Hechter RC, Zeber JE,
Copeland LA, Scherrer JF, Lu CY, Rossom R, Simon GE. (2020). “Chronic
pain diagnoses and opioid dispensings among insured individuals with serious
mental illness”. BMC
Psychiatry, 20(1):1-10.
105) Coppin
JD, Copeland LA, Zeber JE, Jinadatha C.
(2020). “Methods of a study of terminal cleaning of
patient rooms” [invited letter]. Infection
Control & Hospital Epidemiology, 41(3):375-6.
104) Zeber JE, Coppin JD, Villamaria
FC, Williams MD, Copeland LA, Chatterjee P, Choi H, Jinadatha C.
(2019). “Use of ultraviolet irradiation in addition to
commonly used hospital disinfectants or cleaners further reduces the bioburden
on high touch”. Open Forum Infectious Diseases,
17(6):12.
103) Beidas
RS, Jager-Hyman S, Becker-Haimes EM, Wolk CB, Ahmedani BK, Zeber JE,
Fein JA, Brown GK, Gregor CA, Lieberman A, Marcus SC. (2019). “Acceptability and use
of evidence-based practices to promote safe firearm storage in pediatric
primary care for suicide prevention: a survey in two health systems”.
Academic Pediatrics, 19:670-6. PMID:30508600.
102) Jager-Hyman
S, Wolk CB, Ahmedani BK,
Zeber JE, Fein JA, Brown GK, Byeon V, Listeruda H, Gregor CA, Lieberman A,
Beidas RS. (2019). “Perspectives from firearm
enthusiasts on firearm safety promotion in pediatric primary care as a
universal suicide prevention strategy: a qualitative study”.
Journal of Behavioral Medicine,
42:691-701. PMID: 31367934.
101)
Coppin JD, Villamaria FC, Williams MD, Copeland LA, Zeber JE, Jinadatha
C. (2019). “Increased time spent on terminal cleaning of
patient rooms may not improve disinfection of high-touch surfaces”. Infection Control & Hospital Epidemiology,
40(5):605-6. PMID:30905326.
100) Pednekar
P, Ágh T, Raval AD, Malmenas M, Bennett B, Manias EF, Borah BJ, Bunz TJ,
Hutchins D, Hiligsmann M, Turcu-Stiolica A, Williams AF, Zeber JE,
Abrahamyan L, Peterson AM.
(2019). “Measurement issues in defining and determining
adherence to multiple medications”. Value in Health, 22:139-56. PMID:30711058.
99) Copeland LA, Zeber
JE, Thibodeaux LV, McIntyre RT, Stock EM, Hochhalter AK. (2018). “Post-discharge correlates of health literacy among
medicaid inpatients”. Population
Health Management, 21(6):493-500. PMID:29596034.
98) Wolk CB, Van Pelt AE,
Jager-Hyman S, Ahmedani BK, Zeber JE, Fein JA, Brown GK, Gregor CA,
Lieberman A, Beidas RS. (2018). “Stakeholder perspectives on the implementation
of a firearm safety intervention in pediatric primary care as a universal
suicide prevention strategy”. JAMA
Open, 1(7):e185309. PMID:30646398.
97) Stock EM, Zeber JE, McNeal CJ, Banchs JE, Copeland LA.
(2018). “Psychotropic pharmacotherapy associated with QT prolongation among
veterans with posttraumatic stress disorder”. Annals of Pharmacotherapy, 52(9):838-48. PMID:29642718.
96) Waitzfelder
B, Stewart C, Coleman K, Rossom R, Ahmedani B, Beck A, Zeber JE, Daida
Y, Trinacty C, Hubley S, Simon G.
(2018). “Treatment initiation for new episodes of
depression diagnosed in primary care settings”. Journal of General Internal Medicine, 33(8):1283-91. PMID:29423624.
95) Zeber JE, Pfeiffer
C, Baddley J, Cadena-Zuluaga J, Copeland LA, Stock EM, Hendricks J, Mohammadi
J, Restrepo MI, Jinadatha C. (2018). “The effect of
pulsed-xenon ultraviolet room disinfection devices on microbial counts for
methicillin-resistant staphylococcus aureus and aerobic colonies”. American Journal of Infection Control,
46:688-73. PMID:29655672. [** lead
article featured in VA Office of Research & Development newsletter, May
2018]
94) Stock EM, Stamey JD, Zeber
JE, Thompson AW, Copeland LA..
(2018). “A Bayesian approach to modeling risk of
hospital admissions associated with schizophrenia accounting for
under-diagnosis of the disorder in administrative records”. Computational
Psychiatry, 2:1-10. PMID:30090859.
93) Cho J, Stock EM, Quinn CC, Zeber JE, Ahmedani BK,
Basu R, Quinn C, Liao I, Copeland LA. (2018). “Multiple chronic
condition profiles and mortality among oldest-old male patients with hip fracture:
data from the Veterans Health Administration”. Journal of Gerontology & Geriatrics, 74:184-190. PMID:29126081.
92) Zeber
JE, Coleman KJ, Fischer H, Yoon T, Ahmedani BK, Beck A, Hubley S, Imel Z,
Rossom R, Shortreed S, Stewart C, Waitzfelder BE, Simon G.
(2017). “The impact of race and ethnicity on rates of
return to psychotherapy for depression”. Depression & Anxiety, 34:1157-63. PMID:29095538.
91) Wolk CB, Jager-Hyman S,
Marcus SC, Ahmedani BK, Zeber JE, Fein JA, Brown GK, Lieberman A, Beidas
RS. (2017). “Developing
implementation strategies with stakeholders to promote firearm safety as a
suicide prevention strategy in pediatric primary care”. BMJ
Open, v7:e1044067. PMID:28647722.
90) Coppin JD, Villamaria FC, Williams MD, Copeland LA, Zeber
JE, Jinadatha C. (2017). “Self-sanitizing embedded-copper surfaces in
the patient room for infection control”. American
Journal of Infection Control, 45(6):692-4. PMID:28237738.
89) Dixon JL, Copeland LA, Zeber
JE, MacCarthy AA, Reznik SI, Smythe RW, Rascoe PA. (2016). “Association
between diabetes and esophageal cancer, independent of obesity, in the US
Veteran’s Affairs (VA) population.” Diseases of the Esophagus,
v29(7):747-51. PMID:26455587.
88) Stock EM, Copeland LA,
Tsan JY, Zeber JE, Verontin MA, Thompson AW. (2016). “Method of analysis as a factor in models of admission among
veterans of Iraq and Afghanistan deployments”. Military Medicine, 181(10):1248-57.
PMID:27753560.
87) Rossom RC, Shortreed S,
Coleman KJ, Beck A,Waitzfelder BE, Stewart C, Ahmedani B, Zeber JE,
Simon GE. (2016). “Predictors of antidepressant
adherence across diverse healthcare settings”. Depression & Anxiety, 33:765-774. PMID:27320786.
86) Coleman KJ, Stewart C, Waitzfelder B, Zeber
JE, Morales L, Ahmed A, Ahmendani B, Beck A, Copeland LA, Cummings J,
Hunkler E, Lindberg N, Lynch F, Lu C, Owen-Smith A, Quinn V, Trinacty CM,
Whitebird R, Simon GE.
(2016). “Racial and ethnic differences in diagnoses and
treatment for mental health conditions across healthcare systems participating
in the mental health research network”. Psychiatric Services, 67(7):749-57. PMID:27079987.
85) Tsan JY, Stock EM, Greenawalt DS, Zeber JE, Copeland
LA. (2016). “Mental health treatment after major surgery among Vietnam Era
Veterans with posttraumatic stress disorder”. Journal of Health Psychology, 21(7):1249-60. PMID:25305191.
84) Blackburn D, Romers C,
Copeland LA, Nguyen D, Lynch W, Zeber JE, Hoffman M. (2016). “Role of pre-surgical psychological assessments and
effectiveness of spinal cord stimulation for chronic pain reduction”.
Neuromodulation, 19(6):422-28. PMID:27028312.
83) Cho J, Copeland LA, Zeber JE, Stock EM, Stevens AB, MacCarthy
AA, Restrepo MI. (2016).“Health services utilizations among the oldest
veterans”. Journal
of the American Geriatrics Society, 64(6):1250-7. PMID:27321603.
82) Villamaria FC, Berlanga G, Liao I,
Ganachari-Mallappa N, Stock EM, Zeber JE, Jinadatha C.
(2015). “Comparison of environmental MRSA levels on
high touch surfaces in contact isolation and non-contact isolation patient rooms”.
Infection Control
and Hospital Epidemiology, 36(12):1472-75. PMID:26311001.
81) Basu R, Zeber JE,
Copeland LA, Stevens AB. (2015). “Role of co-existence
of multiple chronic conditions on the longitudinal decline in cognitive
performance among older adults in the US”. Journal of Gerontology & Geriatrics Research, S4:004.
80) Evans LD, Stock EM, Zeber
JE, Morissette SB, MacCarthy AA, Sako EY, Lappin J, Lawrence VA, MacCarthy DJ,
Copeland LA. (2015). “Post-transplantation outcomes in veterans with
serious mental illness”. Transplanation,
99(8):e57-65. PMID:25706275.
79) Jinadatha C, Villamaria FC, Restrepo MI, Ganachari-Mallappa
N, Liao I, Stock EM, Copeland LA, Zeber JE. (2015). “Is the pulsed xenon
ultraviolet light no touch disinfection system effective on MRSA in the absence
of manual cleaning?” American Journal of
Infection Control, 43:878-81. PMID:26014583.
78) Hutchins D, Zeber JE, Roberts C,
Williams AF, Manias EF, Peterson AM. (2015). “Initial
medication adherence - review and recommendations for good practices for
outcomes research: an ISPOR medication adherence and persistence special
interest group peport”. Value in
Health, 18(5):690-9. PMID:26297098.
77) Copeland LA, Zeber JE, Sako
E, Mortensen EM, Pugh MJ, Wang CP, Restrepo MI, Flynn J, MacCarthy AM, Lawrence
VA. (2015). “Serious mental illnesses associated with receipt of surgery in
retrospective analysis of patients in the Veterans Health Administration”. BMC Surgery,
15:74. PMID:26084521.
76) Phillips KL,
Copeland LA, Zeber JE, EM Stock,
Tsan JY, MacCarthy AA. (2015). “Racial/ethnic disparities in monitoring and
treating metabolic parameters among schizophrenia patients receiving
antipsychotic medications”. American
Journal of Geriatric Psychiatry, 23(6): 596-606. PMID:25154537.
75) Jinadatha C, Villamaria FC, Copeland LA, Ganachari-Mallappa
N, Brown DS, Liao I, Stock EM, Zeber JE. (2015). “Can pulsed xenon ultraviolet disinfect aerobic bacteria in
the absence of manual disinfection?” American
Journal of Infection Control, 43:415-7. PMID:25681301.
74) Stock EM, Kimbrel NA, Meyer EC, Copeland LA, Monte R, Zeber
JE, Gulliver SB, Morissette SB (2014). “A bayesian
model averaging approach to examining changes in quality of life during
reintegration into civilian life among returning Iraq and Afghanistan veterans”.
International Journal of Methods in
Psychiatric Research, 23(3):345-58. PMID:24942672.
73) Copeland LA, Sako EY, Zeber JE, Pugh MJ, Wang CP,
MacCarthy AA, Restrepo MI, Mortensen EM, Flynn J, Lawrence VA. (2014). “Mortality
after cardiac operations by pre-existing severe mental illness status”.
General Hospital Psychiatry, 36(5):502-8.
PMID:24957928.
72) Copeland LA McIntyre
R, Stock E, Zeber JE, MacCarthy DJ, Pugh MJ. (2014). “Prevalence of
suicidality among hispanic and african-american patients following surgery”. American Journal of Public Health,
104(S4):603-8. PMID:25100427.
71) Sun FF, Stock EM,
Copeland LA, Zeber JE, Ahmedani BK, Morissette SB. (2014). “Comparison
of antipsychotic polypharmacy trends among schizophrenia patients across
multiple healthcare systems”. American Journal of Health System Pharmacy,
71(9):728-38. PMID:24733136.
70) Jinadatha
C, Quezada R, Huber TW, Williams JB, Zeber JE, Copeland LA. (2014).
“Evaluation of a pulsed-xenon ultraviolet room disinfection device
for impact on contamination levels of methicillin-resistant staphylococcus
aureus”. BMC Infectious
Diseases, 14:187. PMID:24708734.
69) Noel PH, Parchman ML, Palmer RF, Romero R,
Leykum LI, Lanham HJ, Zeber JE, Bowers KW. (2014). “Alignment
of patient and primary care practice member perspectives of chronic illness
care: a cross-sectional analysis”. BMC
Family Practice, 15:57. PMID:24678983.
68) Penfold RB, Stewart C, Hunkeler EM, Madden JM, Cummings JR,
Owen-Smith AA, Rossom RC, Lu CY, Lynch FL, Waizfelder BE, Coleman KA, Ahmedani
BK, Beck AL, Zeber JE, Simon GE.
(2013). “Use of antipsychotic medications in pediatric populations: what do
the data say?” Current
Psychiatry Reports:15(12):426-35. PMID:24258527;
67) Greenawalt DS, Copeland LA. MacCarthy AM, Sun FF, Zeber JE,
(2013). “Post-traumatic stress disorder, major depressive disorder and
likelihood of invasive surgery: a retrospective longitudinal study among VA
patients”. Journal of Psychosomatic
Research, 75(4):386-93. PMID:24119948.
66) Stock EM, Copeland LA,
Bush R, Zeber JE. (2013). “Prevalence
of QT prolongation among veterans with severe mental health disorders”.
Psychiatric Services, 64(10):942.
PMID:24081399.
65) Copeland
LA, Zeber JE. (2013). “Advancing research in the era of healthcare reform: 19th
annual HMO research network conference”. Clinical
Medicine & Research, 11(3):120-22. PMID:24085855.
64) Pugh MJ, Marcum ZA, Copeland LA, Mortensen EM, Zeber
JE, Noël PH, Berlowitz DR, Downs JR, Good CB, Alvarez C, Amuan ME, Hanlon
JT. (2013). “HEDIS
quality measures for medication management in the elderly: outcomes associated
with new exposure”. Drugs and
Aging, 30(8):645-54. PMID:23645530.
63) Zeber JE, Manias
EF, Williams AF, Hutchins D, Udezi WA, Roberts CS, Peterson AM. (2013). “A systematic literature review of psychosocial and behavioral
factors associated with initial medication adherence: a report of the ISPOR
medication adherence & persistence special interest group”. Value in Health, 16(5):891-900. PMID:23947984.
62) Culler SD, Parchman ML, Romero-Lozano R, Noel PH, Lanham HJ,
Leykum LK, Zeber JE. (2013).
“Cost
estimates for operating a primary care facilitation program”. Annals of Family Medicine, 11(3):207-11.
PMID:23690319.
61) Blackburn DR, Monte RC, Zeber JE, McIntyre R. (2013). “Assessment
of psychological screeners for spinal cord stimulation success”. Practical Pain Management, 3:35-9.
60) Tsan JY, Zeber JE, Stock EM, Copeland
LA. (2012). “Primary care mental health integration and persistence in care
among Iraq and Afghanistan war veterans”. Psychological
Services, 9(4):336-48. PMID:22545824.
59) Tsan JY, Stock EM, Gonzalez JM, Greenawalt DS, Zeber JE,
Rouf E, Copeland LA. (2012). “Mortality and
guideline-concordant care for older patients with schizophrenia: a
retrospective longitudinal study”. BMC
Medicine, 10:147. PMID:23181341.
58) Pugh MJ, Copeland LA, Zeber
JE, Wang CP, Amuan ME, Mortensen EM, Tabares J, Van Cott AC, Cooper T,
Cramer JA. (2012). “Antiepileptic drug monotherapy exposure and
suicide-related behavior in older veterans”. Journal of the American Geriatrics Society, 60(11):2042-47. PMID:23110401.
57) Williams EO, Stock EM, Zeber
JE, Copeland LA, Miller NA, Stuart M, Palumbo F. (2012). “Payor types associated with antipsychotic polypharmacy in an
ambulatory care setting”. Journal of
Pharmaceutical Health Services Research, 3(3):149-55.
56) Maples NJ, Copeland LA, Zeber JE, Li
X, Moore TA, Dassori D, Velligan DI, Miller AL. (2012). “Can medication
management coordinators help improve continuity of care after psychiatric hospitalization?”.
Psychiatric Services, 63(6):554-60.
PMID:22476107.
55) Mackey K, Parchman MP, Leykum LK, Lanham HJ,
Noel PH, Zeber JE. (2012). “Impact
of the chronic care model on medication adherence when patients perceive cost
as a barrier”. Primary Care Diabetes,
6(2):137-42. PMID:22264426.
54) Arar N, Noel PH, Leykum LK, Zeber JE, Romero
RR, Parchman ML. (2011). “Implementing quality improvement in small,
autonomous primary care practices: implications for the patient centered
medical home.” Quality in
Primary Care; 19(5): 289-300. PMID:22186171.
53 Zeber JE, Gonzalez JM, VanDorn RA,
Interian A. (2011). “The challenge of incorporating cultural issues
into depression treatment: translating diverse current research approaches into
clinical practice” [editorial]. Depression
Research & Treatment; 2011:195084. PMID:22110911.
52) Copeland LA, Zeber JE, Pugh MJ, Phillips
KL, Lawrence VA. (2011). “Ethnicity and race variations in receipt of
vascular surgery among veterans with and without depression”. Depression Research & Treatment; 2011:370962.
PMID:22013518.
51) Noel PH, Zeber JE,
Pugh MJ, Finley EP, Parchman ML. (2011). “A pilot survey of post-deployment
health care needs in small community-based primary care clinics”. BMC Family Practice, 12:79. PMID:21801356.
50) Copeland LA, Ettinger AB, Zeber JE,
Gonzalez JM, Pugh MJ. (2011). “Psychiatric and medical admissions observed among
elderly patients with new-onset epilepsy”. BMC Health Services Research, 11:84. PMID:21504584.
49) Copeland LA, Zeber JE,
Bingham MO, Pugh MJ, Noël PH, Schmacker ER, Lawrence VA. (2011). “Transition from military to VHA care:
Psychiatric health services for Iraq/Afghanistan combat-wounded”. Journal
of Affective Disorders, 130(1-2):226-30. PMID:21051088.
48) Zeber JE, Miller AL, Copeland LA,
McCarthy JF, Zivin K, Valenstein M, Greenwald D, Kilbourne AM. (2011) “Medication
adherence, ethnicity, and the influence of multiple psychosocial and financial
barriers.” Administration
& Policy in Mental Health / Mental Health Services Research,
38(2):86-95. PMID:20549327.
47) Dassori AM,
Copeland LA, Zeber JE, Miller AL. (2011). “Factors in antipsychotic switching patterns in a national
sample of older veterans with schizophrenia”. Psychiatric Services, 62(1):47-53. PMID:21209299.
46)
Gonzalez JM, Alegria M, Prihoda TJ,
Copeland LA, Zeber JE. (2011). ”How the
relationship of attitudes toward mental health treatment and service use
differs by age, gender, ethnicity/race and education”. Social Psychiatry & Psychiatric Epidemiology, 46(1):45-57.
PMID:19921079.
45) Finley EP, Zeber JE,
Pugh MJ, Cantu G, Copeland LA, Parchman ML, Noel PH. (2010). “Post-deployment
healthcare for returning OEF/OIF military personnel and their social networks:
a qualitative approach”. Military
Medicine, 175(12):953-7. PMID:21265301.
44) Zeber JE, Noel PH, Pugh MJ, Copeland
LA, Parchman ML. (2010). “Family perceptions of post-deployment healthcare
needs of Iraq/Afghanistan military personnel”. Mental Health in Family Medicine, 7(3):135-43. PMID:22477935.
43) Zeber JE, Copeland LA, Pugh MJ.
(2010). “Variation in antiepileptic drug adherence among older patients with
new-onset epilepsy”. Annals of
Pharmacotherapy, 44(12):1896-904. PMID:21045168.
42) McCarthy JF, Valenstein
M, Zivin K, Zeber JE, Kilbourne AM. (2010). ” Access-related
measures and out-of-system utilization among veterans patients with bipolar
disorder”. Psychiatric Services, 61(10):1035-8.
PMID:20889645.
41) Copeland
LA, Parchman ML, Zeber JE, Lawrence VA, Downs JR, Miller AL. (2010). “Pre-diabetes assessment
and follow-up in veterans with schizophrenia”. American Journal of Geriatric Psychiatry, 18(10):887-96. PMID:20808110.
40) Parchman ML, Zeber JE, Palmer RF.
(2010). ” Participatory
decision making, patient activation, medication adherence and intermediate
clinical outcomes in type 2 diabetes: a STARNet study”. Annals of Family Medicine, 8(5):410-7. PMID:20843882.
39) Zeber JE, Parchman ML. (2010). “Cardiovascular
disease in type 2 diabetes: attributable risk due to modifiable risk factors”. Canadian
Family Physician, 56(8):302-7.
PMID:21733872
38) Van Cott AC, Cramer JA, Copeland LA, Zeber
JE, Steinman MA, Dersh JJ, Glickman ME, Mortensen EM, Amuan ME, Pugh MJ.
(2010). “Suicide-related behaviors in older patients with new anti-epileptic
drug use: data from the VA Hospital System”. BMC Medicine, 8:4. PMID:20064226.
37) Ettinger AB, Copeland LA, Zeber JE,
Van Cott AC, Pugh MJ. (2010). “Are psychiatric disorders independent risk
factors for new-onset epilepsy in older individuals?” Epilepsy & Behavior, 17(1):70-4. PMID:19913462.
36) Evans-Lacko
SE, Zeber JE, Gonzalez JM, Olvera RL. (2009). “Medical comorbidity
among youth diagnosed with bipolar disorder in the United States.“ Journal of Clinical Psychiatry, 70(10):1461-66.
PMID:19744408.
35) Medication
Adherence Expert Panel (Velligan DI, chair). (2009) “The expert
consensus guideline series: adherence problems in patients with serious and persistent
mental illness.” Journal of Clinical
Psychiatry, 70(suppl 4):1-46. PMID:19686636.
34) Perron BE, Zeber JE, Kilbourne AM,
Bauer MS. (2009). “A brief measure of perceived clinician support by patients
with bipolar spectrum disorders”. Journal
of Nervous and Mental Disorders, 197(8):574-9. PMID:19684493.
33) Copeland LA, Zeber JE, Wang CP,
Lawrence VA, Parchman ML, Valenstein M, Miller AL. (2009). “Patterns of primary
care and mortality among patients with schizophrenia or diabetes: a cluster
analysis approach to a retrospective study of healthcare utilization”. BMC Health Services Research, 9:127-37.
PMID:19630997.
32) Hope OA, Zeber JE,
Kressin NR, Bokhour BG, VanCott AC, Cramer JA, Amuan ME, Knoefel JE, Pugh MJ.
(2009). “New-onset geriatric epilepsy care: race, setting of diagnosis and choice
of antiepileptic drug”. Epilepsia, 50(5):1085-93.
PMID:19054416.
31) Ilgen MA,
Czyz EK, Welsh DE, Zeber JE, Bauer MS, Kilbourne AM. (2009). “A collaborative therapeutic
relationship and risk of suicidal ideation in patients with bipolar disorder”. Journal of Affective Disorders, 115(1):246-51.
PMID:18774179.
30) Copeland LA, Miller AL, Welsh DE, McCarthy
JF, Zeber JE, Kilbourne AM. (2009). “Clinical and
demographic factors associated with homelessness and incarceration among VA
patients with bipolar disorder”. American
Journal of Public Health, 99(5):871-77. PMID:19299667.
29) Zeber JE,
Copeland LA, McCarthy JF, Bauer MS, Kilbourne AM. (2009). “Perceived
access to general medical and
psychiatric care among veterans with bipolar disorder”. American Journal of Public Health, 99(4):720-7.
PMID:19150912.
28) Zeber JE, Pearson D, Thompson D. (2009).
“Analysis of health appointment no-shows”. Primary
Health Care, 19(2):25-9. PMID:17674165.
27) Copeland LA, Lawrence VA, Zeber JE. (2009). “Depression and the
long-term effects on postoperative outcomes [letter]”. Annals of Surgery, 249(2):353-4.
26) Zeber JE, Copeland LA,
Hosek BJ, Karnad AB, Lawrence VA, Sanchez-Reilly SE. (2008). “Cancer rates, medical
comorbidities, and treatment modalities in the oldest patients”. Critical Reviews in Oncology /Hematology,
67(3):237-42. PMID:18356072.
25) Pugh MV, Zeber JE, Copeland LA, Tabares
JV, Cramer J. (2008). “Psychiatric disease burden profiles among
veterans with epilepsy: the association with health services utilization”.
Psychiatric Services, 59(8):925-8.
PMID:18678692.
24) Copeland LA, Zeber JE, Pugh
MJ, Mortensen EM, Restrepo MI, Lawrence VA. (2008). “Postoperative complications in the seriously
mentally ill: a systematic review of the literature". Annals of Surgery, 281(1):31-8. PMID:18580204.
23) Velligan DI, Diamond PM, Mintz J, Maples N,
Li X, Zeber JE, Ereshefsky L, Lam YW, Castillo D, Miller AL. (2008).
“The use of individually tailored environmental supports to improve medication
adherence and outcomes in schizophrenia”. Schizophrenia
Bulletin, 34(3):483-93. PMID:17379319.
22) Zeber JE, Copeland LA, Good CB, Fine
MJ, Bauer MS, Kilbourne AM. (2008). “Therapeutic alliance perceptions and
medication adherence in patients with bipolar disorder”. Journal of Affective Disorders, 107(4):53-62. PMID:17822779.
21) Copeland LA, Zeber JE, Salloum IM,
Pincus HA, Fine MJ, Kilbourne AM. (2008). “Treatment adherence and
illness insight in veterans with bipolar disorder”. Journal of Nervous and Mental Disorders,
196(1):16-21. PMID:18195637
20) Noël PH, Parchman ML, Williams JW, Cornell
JE, Lee S, Zeber JE, Kazis LE, Lee AF, Pugh JA. (2007). “The challenges
of multimorbidity from the patient perspective” Journal of General Internal Medicine, 22(supp3):419-24. PMID:18026811.
19) Parchman ML, JE Zeber,
Romero RR, Pugh JA. (2007).
“Risk
of coronary artery disease in type 2 diabetes and the delivery of care
consistent with the chronic care model in primary care settings: a STARNet
Study”. Medical Care,
45(12):1129-34. PMID:18007162.
17) Cornell J, Pugh JA, Williams JW, Kazis L, Lee
AF, Parchman ML, Zeber JE, Pederson T, Montgomery KA, Noël PH. (2007). “Multimorbidity
clusters: clustering binary data from a large administrative medical database”.
Applied Multivariate Research,
12(3):163-82.
16) Zeber JE, Grazier KL, Valenstein M,
Blow FC, Lantz PM. (2007). “Effect of a medication
copayment increase in veterans with schizophrenia”. American Journal of Managed Care, 13(6, part 2):335-46. PMID:17567234.
15) Zeber JE, Copeland LA, Amuan ME, Cramer
JA, Pugh MJ. (2007). “The role of comorbid psychiatric
conditions in health status in epilepsy”. Epilepsy and Behavior, 10(4): 539-46. PMID:17416208.
14) Kilbourne AM, Post EP, Bauer MS, Zeber JE,
Copeland LA, Good CB, Pincus HA. (2007). “Therapeutic drug and cardiovascular
disease risk monitoring in patients with bipolar disorder”. Journal of Affective Disorders,
102(1-3):145-51. PMID:17276514.
13) Zeber JE, McCarthy JF, Bauer MS,
Kilbourne AM. (2007). “Datapoints: self-reported access to general medical and
psychiatric care among veterans with bipolar disorder”. Psychiatric Services, 58(6):740. PMID:17535932.
12) Copeland LA, Mortensen EM, Zeber
JE, Pugh MJ, Restrepo MI, Dalack GW. (2007). “Pulmonary disease among
inpatient decedents: Impact of schizophrenia”. Progress in Neuro-Psychopharmacology & Biological Psychiatry,
31(3):720-6. PMID:17292522
11) Pugh MJ, Hanlon JT, Zeber JE,
Bierman A, Cornell J, Berlowitz DR. (2006).
“Assessing potentially inappropriate prescribing in the elderly veterans
affairs population using the HEDIS 2006 quality measure”. Journal of Managed Care Pharmacy, 12(7):537-45. PMID:16981799.
10) Zeber JE, Copeland LA,
Grazier KL. (2006). “Serious
mental illness, aging, and utilization patterns among veterans”. Military Medicine, 171(7):619-26. PMID:16895128.
9) Copeland LA, Zeber JE, Rosenheck RA, Miller AL. (2006).
“Unforeseen inpatient
mortality among veterans with schizophrenia”. Medical Care, 44(2):110-6. PMID:16434909.
8) Pugh MJ, Copeland LA, Zeber JE, Cramer JA, Amuan ME,
Cavosos JE, Kazis LE. (2005). “The
impact of epilepsy on health status among younger and older adults”. Epilepsia,
46(11):1820-7. PMID:16302863.
7) Blow FC, Zeber JE, McCarthy JF, Valenstein M, Gillon L,
Bingham CR. (2004). “Ethnicity and diagnostic patterns in veterans with
psychoses”. Social Psychiatry & Psychiatric Epidemiology,
39(10):841-51. PMID:15669666.
6) Valenstein M, Blow FC, Copeland LA, McCarthy JF, Zeber JE,
Gillon L, Bingham CR, Stavenger T. (2004). “Poor antipsychotic adherence among
patients with schizophrenia: medication and patient factors”. Schizophrenia Bulletin, 30(2):255-64. PMID:15279044.
5) Copeland LA, Zeber JE, Valenstein M,
Blow FC. (2003). “Racial disparity in the use of atypical antipsychotic
medications among veterans” American Journal of Psychiatry,
160(10):1817-22. PMID:14514496.
4) Barry KL, Zeber JE, Blow FC,
Valenstein M. (2003). “Effect of strengths model versus assertive community
treatment model on participant outcomes and utilization: two-year follow-up”. Psychiatric Rehabilitation Journal,
26(3):268-77. PMID:12661529.
3) Valenstein M, Copeland LA, Blow FC, McCarthy
JF, Zeber JE, Gillon L, Bingham CR, Stavenger T. (2002). “Pharmacy data
identify poorly adherent patients with schizophrenia at increased risk for admission”.
Medical Care, 40(8):630-9. PMID:12187177.
2) Valenstein M, Vijan S, Zeber JE.
(2002). “Should we screen for depression in primary care” [letter]. Annals of Internal Medicine, 136(5):412.
PMID:11342792.
1) Valenstein M, Vijan S, Zeber JE,
Boehm K, Buttar A. (2001). “The cost-utility of screening for depression in
primary care”. Annals of Internal
Medicine: 134(5): 345-60. PMID:11242495. [featured article, with editorial]
Book Chapters:
Epidemiology of co-occurring TBI and PTSD
[in The Neuropsychology of Mild Traumatic Brain Injury and Posttraumatic Stress
Disorder, Oxford Press, 2014 – with Copeland LA, Pugh MJ, Finley EP].
Risk Bearing and Capital Financing Arrangements in
Integrated Health Systems: Concepts and Cases.
With Douglas Conrad, Ph.D,
Grants
FUNDED:
Primary Investigator or Site PI
Post-Marketing Observational
Cardiovascular Safety Study in Patients taking Naloxegol [AstraZeneca
/ FDA, approved and funded for 2015 – 2022] – Principle Investigator on
this national study ($2.3 million)
Intervention
Mapping to Develop Multi-level Implementation Strategies in Partnership with
Stakeholders: Firearms Means Restriction for Suicide Prevention in Pediatric
Primary Care (ASPIRE) [NIMH
R21 - #1R21MH109878-01, approved and funded for 2016-2017] – Rinad Beidas, PI
(5% effort as Site PI).
Trans-America
Consortium of the HCSRN for the PMI® Cohort Program [NIH
Precision Medicine Initiative #OT2OD024610, approved and funded for 2016 – 2019]
– Brian Ahmedani, PI ($4.1 million, 20% effort as Site PI).
Evaluation of the Veterans Choice Act
for Women Veterans [Veterans Affairs QUERI Partnered
Evaluation grant, approved and funded for 2015-2016] – Kristin Mattocks, PI ($755,000
total, 5% effort as Site PI).
Patterns and Experiences of VA
Maternity Care Coordination for Women Veterans [Veterans
Affairs HSR&D merit grant IIR-14-27, approved and funded for 2015 - 2017] –
Kristin Mattocks, PI ($878,000 total, 5% effort as Site PI).
Pulsed Xenon Technology Targeting
Hospital Acquired Infections: Costs and Outcomes. [Veterans
Affairs HSR&D R01 merit grant IIR-12-347-1] – approved and funded for
2013-2016, $781,000 (35% effort as Principle Investigator). Multisite
study to determine the clinical and economic benefits of a new ultraviolet ray
device to efficiently disinfect rooms and destroy harmful microbes.
Scott & White Minority Pre-doctoral
Fellowship [internal Scott & White and Texas A&M funding] –
approved and funded for 2011-2012, $78,00; Principle Investigator).
Proposed and created this new mentored research fellowship, with plans to
further expand program throughout the institution with emphasis of ethnic
disparities.
Evaluating the Feasibility to Measure
the Extent to Which Asthma Mortality Risk is Increased in ADVAIR Users [GlaxoSmithKline]
– Christine Joseph, PI (approved and funded for 2011-2013, 10% effort at Site
PI).
Post-Deployment Health and Transition
into VA Care [VA Locally Initiated Project #66-014] – approved and
funded for 2009, $50,000; Principle Investigator. Interview returning
OEF military personnel and community providers regarding treatment needs,
access issues, comfort providing care, and possible transition into VA system.
Effect
of Copayments among Veterans with Bipolar Disorder [Lilly] – approved and
funded for 2010, $56,556, Principle Investigator. Examine the effect of
higher VA medication copayments on prescriptions for mood stabilizers and
atypical antipsychotics, along with health services utilization and costs (ER,
hospital).
Post-Operative
Outcomes and Safety in Schizophrenic Elders
[Veterans Affairs VISN 17 grant XVA-66-016] – approved and funded for 2008-2009
($100,000, Principle Investigator). Secondary
database analysis collecting pilot data on potential differences in surgery
rates and outcomes between patients with serious mental illness (schizophrenia,
bipolar, PTSD) and veterans without psychiatric conditions. Study will explore
issues of competing demands and treatment delays leading to greater surgical
needs and clinical ramifications (e.g., relapse rates, mortality).
Medication Adherence, Outcomes and
Quality of Life Perceptions [PhRMA Foundation young investigator research
starter grant, Principle Investigator] – approved and funded for
2007-2008 ($60,000). Explore multidimensional aspects of medication adherence
in patients with schizophrenia, plus quality of life and health status
outcomes. In a national cohort study of schizophrenia patients receiving care
between 1999-2005 (N=90,000): 1) statistically identify clinically-relevant
adherence sub-groups; 2) compare groups across multiple administrative and
SF-36 variables; 3) assess quality of life by mapping SF-36 values to
utilities. Other outcomes include associating adherence / preferences to
utilization and pharmacy costs.
Multi-disciplinary Clinical Training
Program awardee [University of Texas Health Science
Center at San Antonio] – approved and funded for 2006-2008 (50% effort, Principle
Investigator / Career Development Award). Application
to a new young investigator training (K12) program ranked #3 of 19 submissions
for a program designed to encourage collaboration between multiple VA and
university departments, gain clinical mentoring outside one’s primary field,
and provide overall career development guidance as an independent researcher.
Aging and Serious Mental Illness among
Veterans. Veteran Affairs Locally Initiating Project (LIP - #41-095).
Small grant program for young investigators – approved and funded in August
2002, $10,000. Principle Investigator. Local funding for independent
project examining the association between age, psychiatric diagnosis, and
utilization.
FUNDED: Co-Investigator / Consultant / other
The Role of Insurance
Networks and Organizational Factors in Guideline- Concordant Care for Serious
Mental Illness [NIMH 1R34MH123628,
approved and funded 2021-2023] – Kimberley Geissler, PI (10% effort as co-I).
Burdens of
Multimorbidity on Hospitalization and Mortality in Nursing Home Residents with
Obesity [NIA R03, approved
and funded 2020-2023] – Ning Zhang, PI (5% effort as co-I).
Trial to Explore the Benefits of
Antimicrobial Self-Sanitizing Surfaces on Bio-burden levels and
Healthcare-Acquired Infections [AHRQ R01 #1R01HS025598-01A1, approved
and funded 2019 - 2024] – Chetan Jinadatha, PI (10% effort as Co-Investigator).
Evidence Based Practices for
Ultraviolet Disinfection in the Clinical Environment [Department
of Defense TriService Nursing Research Program HU00011920062 (N19-A05),
approved and funded 2019-2020] – Gordon West, PI (consultant).
Healthcare Surfaces Disinfection:
Investigation into the Antibacterial Effect of Copper-Infused Surfaces for
Patient Rooms [Central Texas VA internal award, approved
and funded for 2016-2018] – Chetan Jinadatha, PI (15% effort as Co-Investigator).
Addiction Research Network [NIDA,
approved and funded for 2015-2020] – Connie Weisner, PI (5% contributed effort
as Co-Investigator).
Diabetes, Dementia, and Multiple
Chronic Conditions in Patients with Hip Fracture Repair [HMORN-OAIC
AGING Initiative Pilot Project Grant, sub-award of National Institute on Aging
Grant 1R24AG045050-01A1, approved and funded for 2015-2016] – Laurel Copeland,
PI (5% effort as Co-Investigator).
Identifying Specific Non-VHA Healthcare
with the Mental Health Research Network [Veterans Affairs
QUERI proposal, approved and funded for 2015 - 2017] – Laurel Copeland, PI (15%
effort as Co-Investigator).
Mental Health Research Network-II [NIMH
center grant U19MH092201, approved and funded for 2014-2019] – Greg Simon,
overall PI: 1) general infrastructure funding (10% effort as site PI / co-I);
2) Automated Virtual Follow-up to Reduce Premature Treatment Discontinuation -
Robert Penfold, pilot study PI (5% effort as Co-Investigator)
Examining the Interaction of Ethnicity,
Pain, and Mortality among Veterans Undergoing Surgery
[VA Locally Initiated Project, extension of STOPP grant] – approved and funded
for 2011, $15,000, 5% as Co-Investigator. Extension of LA Copeland study,
focusing of linking administrative data to pain scores.
Evaluation of an Ideal Cleaning
Protocol in Acute Care and OR’s, and Evaluating Concept of Possible UV
Resistance of Continuous Disinfection using Surface Coating Technology. [Xenex,
Chetan Jinadatha, PI] – approved and funded for 2013-2014, $115,000 (5% effort
as Co-Investigator). Center funds and several sub-contracts to conduct health
services and laboratory data on HAI, to develop potential interventions and
subsequent grants.
Surgical
Treatment of Women Veterans: Survey of VA and Non-VA Veterans: supplement to Surgical
Treatment Outcomes for Patients with Psychiatric Disorders (STOPP) [Veterans
Affairs HSR&D IIR-09-335], Laurel Copeland, PI; 20% effort as
Co-Investigator.
Longitudinal Transitions in Cognitive
Decline among Older Adults. [Scott & White Research Grants
Program] – Rashmita Basu, PI (5% effort as Co-Investigator), approved and
funded for 2012-2013, $50,000. Statistical analysis of administrative date to
examine factors associated with different trajectories of cognitive decline.
Hybrid Strategies to Improve Health
Care’s Triple Aims: Lessons Learned From the Transformations of Two Health
Systems [Commonwealth Fund] – Robert Reid, PI (5% effort as
Co-Investigator), approved and funded for FY12-13. Examine patient and provider
perceptions of how fee for service structure affects quality of care and
satisfaction in two different large health plans.
Health Literacy and Improving Hospital
Discharge Transitions in a Low-Income Patient Population. [Scott
& White internal Research Grant Program] – Angie Hochalter, PI (5% effort
as Co-Investigator. approved and funded for FY12, $50,000. Intervention to
improve discharge coordination and outcomes in Medicaid cohort.
Evaluation of a Pulsed-Xenon
Ultraviolet Room Disinfection Device for Impact on contamination levels of
C.diff and MRSA [Xenex] – Chetan Jinadatha, PI. (5%
effort as Co-Investigator); approved and funded for FY11, $125,000. Examine
clinical and cost-effectiveness of an automated disinfection device.
Advanced Center for Interventions and
Service Research (ACISR) for Optimizing Long Term Outcomes in Bipolar Illness
Interventions in Hispanic Communities (NIH proposal - UTHSCSA Department of
Psychiatry P30 – Charles Bowden, PI. (5% overall
effort as Co-Investigator); approved and funded for 2008 - 2013, $1.4 million. –
1) Cultural competency and reduced ethnic disparity in psychiatric diagnosis
for a predominantly Hispanic region (John Zeber, PI – 10% effort); 2)
Personalized Interventions to Improve Treatment Engagement (Adherence) in
Bipolar Disorder: Academic and Community Sites (Jodi Gonzalez, PI – 7% effort
as co-I.). The ACISR is designed to strengthen interdisciplinary interventions
research in bipolar disorders with a focus on the needs of the Hispanic
American community. Working with the South Texas community of patient groups,
advocates, and mental health providers and with
Surgical Treatment Outcomes for
Patients with Psychiatric Disorders (STOPP) [Veterans Affairs
HSR&D IIR-09-335, Laurel Copeland, PI; 25% effort as Co-Investigator. –
approved and funded for FY09-FY10, $381,000. Nothing is known regarding
perioperative risk management and outcomes for veterans with severe mental
illness, and by design, the NSQIP is powerless to address this lack. This
retrospective cohort study uses VA administrative data from FY05 to FY09 to compare
surgery rates and postoperative outcomes (30-day mortality, myocardial
infarction and acute coronary syndrome, deep venous thrombosis or pulmonary
embolism, ICU admission, pneumonia, respiratory failure, sepsis, wound
infection, readmission) by pre-existing SMI status, adjusting for comorbidity
and demographic variables.
Retrospective Database Examination of
Longitudinal Outcomes in Burned OEF/OIF Veterans [Veterans
Affairs HSR&D merit supplement] – Val Lawrence, PI. (10% effort as Co-Investigator).
Additional aim to examine differential mortality rates across diagnostic groups
with death index data.
Role of Clinical Team Functioning and
Medication Adherence in Diabetes [Veterans Affairs HSR&D merit supplement
IIR-06-063, Mike Parchman, PI] – approved and funded for FY09-FY10, $141,000
for supplement only (15% as Co-Investigator). Additional
aim to examine clinical microsystem learning and medication adherence.
Mortality Risk in Veterans with
Schizophrenia and Comorbid Diabetes [Veterans Affairs HSR&D merit
supplement, Laurel Copeland, PI] – approved and funded for FY09-FY10, $50,290
(10% as Co-Investigator). Additional aim to examine differential mortality
rates across diagnostic groups with death index data.
Feasibility of Tracking OEF/IEF
Transition into VA Care [Veterans Affairs HSR&D special
short-term rapid response proposal, Laurel Copeland, PI] – approved and funded
for 2008, $35,600 (10% effort as Co-Investigator). Using VA administrative
data, track transition rates of soldiers leaving DoD and entering the VA
healthcare system.
Incorporating Medicare Pharmacy Data
into an Analysis of Potentially Inappropriate Prescribing in Elderly Veterans
[Veterans Affairs HSR&D merit supplement IIR 06-062, Mary Jo Pugh, PI] – approved
and funded for FY09-FY11, $223,600 (10% as Co-Investigator). Incorporate
Medicare pharmacy data into the analysis to better account for aging veteran
population with dual system use.
Potentially Inappropriate Prescribing
in Elderly Veterans [Veterans Affairs IIR-06-062,
Systematic Review and Tracking Database
for CPG Implementation Research [Veteran Affairs II-R, Valerie
Lawrence, PI] – approved and funded for 2003-2008, $735,400 (5% effort as
Co-Investigator). Systematically review the
literature on organizational strategies of implementing evidence-based medicine
into clinical practice; designed to improve the quality of care provided to
veterans with QUERI diseases – high prevalence, chronic conditions (e.g.,
diabetes, CHF, colon cancer, schizophrenia, depression, etc.)
Patterns
of Late-life Healthcare among VA patients with Schizophrenia
[Veteran Affairs IIR-05-326, Laurel Copeland, PI] – approved and funded for
2006-2008, $273,200 (20% effort as Co-Investigator). Describe and analyze
current patterns of inpatient and outpatient medical, psychiatric, and other
care for veterans age 50+ with schizophrenia with or without diabetes;
determine correlates of care and relationship of patterns to mortality.
Improving substance abuse treatment in the borderland:
early intervention and follow-up in remote primary care clinics [Veteran Affairs special funding RFP; Steve Holliday, PI] – approved and
funded for 2005-2007, ($736,990; 5% effort as Co-Investigator). Provide substance abuse
interventions in a stepped care program for veterans in remote clinics near the
Mexico-Texas border. This demonstration project will seek out at-risk veterans
to engage them in treatment for substance abuse (alcohol, tobacco, other drugs).
The 3-year evaluated implementation project will augment and integrate with
clinical care currently being offered in three satellite clinics in an
impoverished, largely Hispanic population.
Implementing integrated
behavioral health care for predominantly Hispanic OEF/OIF veterans [Veteran Affairs special funding RFP; Steve Holliday, PI] –
approved and funded for 2005-2007, ($586,442; 5% effort as Co-Investigator). Provide comprehensive,
integrated care for returning OEF/OIF veterans, including screening and
treatment for substance abuse (alcohol, tobacco, other drugs), depression,
PTSD, and medical care as well as job services. The target population lives in
an underserved region of
Improving Medication Adherence among
Veterans with Schizophrenia. [Veterans Affairs grant #IIR01-074-1;
Marcia Valenstein, PI] – approved and funded for 2001-2005, 30% effort as
research associate. Multi-site (4 VA) 18-month intervention study designed to
improve medication adherence among veterans with serious mental illness;
primary component was a simple blister-pack, with some pharmacy education and
provider notification of missed refills.
Adopting Best-practices in Community Settings: The ABCs of
Treatment for Schizophrenia. [funding from Texas Department of Mental Health and
Mental Retardation (TDMHMR) and AstraZeneca; Alexander Miller, PI. Invited to serve as consultant on funded project
examining an intervention (cognitive adaptation training) designed to improve
functioning and treatment adherence, reduce inpatient utilization, and minimize
jail experiences in low-income patients with schizophrenia. One significant
analysis will focus on the cost-effectiveness of this intervention (consultant).
Interviews / Press Articles / Newsletters / Briefs:
Efforts to Reduce Poyential Ethnic or Gender Disaprities in Mental Health
Diagnosis and Treatment [Washington Post
interview, May 2019]
Researchers: Adding Gun Safety to Health Care ‘Essential’ to Reducing
Teen Suicide [PBS Springfield, MA “In Conncetions” live
segment and Inside Umass Amherst Weekly, January / February 2019 – interviews
on firearms saftey study and JAMA Open article]
Why Integrated Delivery Systems are Evolving in the Era of Accountable
Care: The Case Studies of Group Health and Scott & White [Commonwealth Fund Issue Brief, 2016]
Value in Health press release, July
2013: Systematic Review of Initial Medication Adherence
SCOPE: Newsletter of the Central Texas Veterans Research Foundation (Volume 5, Fall 2012). Profile of CAHR, its co-directors and projects.
Prescriptions for Progress, September 2007 (vol.2,
no.1) and December 2007 issues (vol.2, no.2): Two policy newsletters presenting
my work on copayments, ethnicity, and clinical impact.
CNS Senior Care, June 2006 issue: brief
telephone interview and article on issues pertaining to ethnicity, cultural competency,
potential diagnostic or treatment disparities, and policy issues among the
elderly with mental health disorders (e.g., medication copayments).
Washington Post, June 2005: “Racial Disparities Found in
Pinpointing Mental Illness”
(6/28/05); includes interview with JE Zeber, based upon 2 published
studies pertaining to ethnic differences in diagnosis and treatment – part
for a series on the subject of mental illness and cultural factors.
Medical Post, June 2004: “Atypicals may
aid compliance in schizophrenics”. Vol 40, Issue 22 (http://www.medicalpost.com).
Reports / White papers:
§
Reports to Commonwealth fund from
“hybrid systems” study: 1) Why Integrated Delivery Systems are Evolving in the
Era of Accountable Care: The Case Studies of Group Health and Scott &
White. Issue Brief prepared for the Commonwealth Fund, September 3, 2013; 2) The
Evolution of Integrated Delivery Systems in the Era of Accountable Care: The
Case Studies of Group Health and Scott & White. Issue Brief prepared for
the Commonwealth Fund, March 14, 2014; 3) Targeting the Triple Aim in the Era
of Accountable Care: Early Experiences of Integrated Delivery Systems Group
Health and Scott & White. Issue Brief prepared for the Commonwealth Fund,
July 15, 2014; 4) The Spread of High-Performance Integrated Care Delivery
Systems: Assessing Two Hybrid Approaches. Report to the Commonwealth Fund,
January 16, 2016. [all by author team - Penfold RB, Fishman PA, Hsu C, Johnson
EA, Ross TR, Copeland LA, Basu R, Hertel E, Zeber JE, Gundersen G, Reid RJ]
§
Blow FC, McCarthy JF, Valenstein M, Zeber
JE, Gillon L. “Care for VA Patients
with Psychoses, 1999-2003” – Part of team that developed the database and co-author
on detailed annual report (5 editions) of all VA patients with serious mental
illness (N=191,000): demographics, psychiatric and medical comorbidities, cost,
utilization, mortality, functional status, access, and pharmacy fills.
Teaching,
mentoring, consulting, and academic advisor roles:
UMass Amherst
(current positon)
Courses Developed and/or Taught:
1. HPP622:
Program Evaluation – HPM core class, 4 times: Spring 2019 (18 students), Spring
2020 (8 students); Spring 2021 (9 students); Spring 2022 (19 students)
2. PH397v:
Veterans Health & the VHA – 3 times, undergraduate elective: Fall 2019 (5
students), Fall 2020 (21 students); Fall 2021 (26 students)
3. PH
129: Health Care for All – 1 time, Spring 2021 (173 students)
4. HPP
896: Independent Study, doctoral course with Gene Garland (Fall 2020)
5. PH
396: Independent Study, 6 undegraduate TA supervison and coordination (Spring
2021)
Invited / Guest Lectures:
·
Fall 2019: Mental health program
evaluation (for Umass Worcester Ulricht doctoral psychology)
·
Spring 2019: Firearms means restriction
(for Whitehill 390D)
·
Fall 2019, Spring 2020, Fall 2021: lectures
on US Health System (for DiFluvio PH200)
·
Fall 2020: PhD research seminar on
professional development (for Zhang/Salerno-Valdez HPP898)
·
Fall 2020: 2 lectures VHA system and
mental health issues (for Chin HPP620)
·
Spring 2021: lecture on disparities in
psychiatric diagnosis (for Goldstien 590A)
·
Fall 2021: PhD research seminar on
medication adherence project (for Zhang/Salerno-Valdez HPP898)
·
Spring 2023: Umass Medical course on
Psychiatric Epidemiology (for Tisminetzky)
Student Advising / Thesis Committees:
·
MPH advisor (9 students through Spring
2022)
·
Honors College thesis committees: 1) Yazhini
Ramesh, chair (AY19-20); 2) Alexandra McQuire, secondary (AY19-20); 3) Caroline
Williams, chair (AY21-22)
·
MPH project advisor: 1) Jacob Lewi
(Spring 2020 - secondary); Erica Ferrera (Spring 2020 – secondary); Ali Ali
(Spring 2021 – primary); Mackenzie Gilligan (Spring 2022 – primary)’ 4) Kesanet
Tesfazion (Fall 2022 – secondary)
·
PhD thesis member: 1) Eugene Garland
(2020-2023 – secondary)
Faculty Roles & Committees, Other
Service:
·
1) HPM program head (2018 – 2021); 2)
Departmental Personnel Committee (member, 2019 – present); 3) PhD admission
committee (co-chair, 2018 – present); 4) MPH admissions committee (chair, 2019
– 2021); 5) online MHA program steering committee (member, 2018 – present); 6) CEPH
accreditation committee (member, 2018 – present); undergraduate advisory
committee (2018 – 2021); scholarship committee (2018 – present)
·
reviewer, Public Service Endowment
Grants (Spring 2020);
Miscellaneous Other Teaching Efforts:
·
In addition to further developing a
personal research portfolio, one of the primary missions of the Center for
Applied Health Research (CAHR) since its 2010 inception was to support clinical
or health services investigators with their own projects, while mentoring a
range of promising researchers. As such, we frequently provide consulting to
numerous people across departments at Baylor Scott & White, the Central
Texas VA, Texas A&M academic affiliates, and other institutions. This
includes assessing their project proposal, data analytical needs,
methodological options, submitting IRB protocols, grant writing, and publishing
or other dissemination efforts. In total, we provided nearly 150 such
consultations here, varying for one-time meetings to long-term collaborations,
rresulting in over 30 known publications (others in progress), several grants,
numerous QI, projects, and substantial overall system impact with tremendous
support from senior leadrship.
·
Created and obtained funding for a new
Scott & White minority pre-doctoral fellowship (2011-2012): interviewed
candidates, developed structured program of mentoring, coursework, meetings
with senior VA, hospital, and academic leaders.
·
Volunteered to mentor summer high
school research interns 2011 – 2018, part of a STEM funded project (NSF) for an
advanced junior college training program, leading to their own poster
presentation.
·
Doctoral thesis / capstone project
committee member: Gordon Black, Frontier School of Nursing (Using the Health Promotion Model to Reduce
Appointment No-Shows in Rural Underserved Community Clinics) - 2011.
·
Teaching assistant at the University of
Washington during graduate school there: 3 semesters, multiple courses in basic
statistics and quantitative methods (masters and exectuive clinical students).
Other InstitutionAL,
Professional Contributions & Service / Teaching Efforts
Invited Presentations / Expert Panels:
Baystate Medical Research Forum
– invited to give presentation on Umass department, personal research
interests, and to develop potential collaborations. (November 2018)
VA HSR&D, cyberseminar
– invited to give national presentation on Population Health Research
Collaborations between Federal and Private Health Care Systems: VA and HMORN. (June
2015)
Baylor Scott & White, grand rounds
for Departments of Medicine and Psychiatry (approximately every
2 years for each department between 2011 – 2018) – Introducing faculty to our
research center, scope of health services projects, offer consulting or
analsytical guidance, discuss the two national rseearch networks and our roles,
updates of current study progress.
Academy Health annual research
conference, Behavioral Health Special Interest Group Meeting (June
2013, Baltimore) – chaired mental health group meeting and abstract selection
committee, then served as invited moderator for a panel discussion
International Society for
Pharmacoeconomics and Outcomes Research annual meeting (May
2013, New Orleans) –
invited to update the board of
directors on international working group projects targeting medication
adherence
Enhancing Research Through
Collaboration Retreat (Baylor University March 2013) – oral
presentation as part of a health services session to increase research
collaboration among several Central Texas institutions.
Texas A&M Rural School of Public
Health Graduate Student Practicum (February 2013) – introduce CAHR to
master students and interview them for summer research placement.
VA Health Economics Research Center,
cyberseminar – invited to give national presentation on several projects
related to copayments, Veterans with chronic conditions, medication adherence,
and patient-centered care. (February 2012)
Texas A&M Department of Psychology,
College Station – invited to give course lecture to
Clinical Psychology program on medication adherence, cost, and other barriers
(February 2012)
Waco Veterans Affairs PTSD Center of
Excellence – invited to give several presentations on projects related
to chronic care delivery, patient-centered care, and medication adherence (2012
- 2016).
Texas A&M School of Rural Public
Health, College Station – invited to give course lecture to
faculty and graduate students in Behavioral Health program on several projects
related to mental health and surgery rates, chronic care delivery,
patient-centered care, and medication adherence (October 2011)
Veterans Affairs HSR&D Center of
Excellence, Houston – invited to present current research
findings at monthly seminar (June 2011)
UTHSCSA Department of Psychiatry Grand
Rounds (December 2010) – Discussion of current findings influencing
poor medication adherence in patients with serious mental illness, including
use of administrative versus primary data collection, along with the clinical
implications of targeting certain risk factors. (invited speaker).
Lead Guest Editor
Depression
Treatment and Research (special journal issue on Ethnicity
and Cultural Competency – published, with editorial, in Fall 2011).
Family
Practice (special journal issue on COVID-19 Implications for Primary
Care Providers and Patients – planned, with editorial, for publication in Fall
2021.
South Texas Practice Based Research Network
(PBRN) Annual Convocation (October 2009) – Shared preliminary findings of a local research project as
invited speaker, surveys from patients and clinicians at 6 clinics regarding
post-deployment health issues.
South Texas Veterans Health Care System
- Psychiatry Grand Rounds (April 2009) – Multiple risk factors for poor medication adherence in veterans
with schizophrenia and bipolar disorder, including demographic, financial, and
psychosocial issues; based upon the literature and our own work with VA
administrative and survey data.
Medication Adherence Expert Consensus
Guideline Panel (Fall 2008) – Invited guest expert contributing to
national working group project to identify risk factors for medication adherence
in patients with serious mental illness, and strategies to address the persistent
problem. Findings published in special supplement of Journal of Clinical Psychiatry (v70, suppl 4, 2009).
Congressional Black Caucus / Center for
Minority Veterans: annual legislative meeting (September
2005) – Invited panelist for forum discussing the implications of ethnic
disparities in mental health diagnosis and treatment, designed to foster
research collaboration between VA, academic and other organizations.
Other
Professional Activities / Leadership Roles / Contributed Effort:
Infectious Disease
Special Interest Group – created and led new working group
within the Health Care Systen Research Network, to design clinically relevant
projects and discussions within network sites (June 2017).
State of Health Care Reform in Texas
– served as advisory panel member for this legislative and health policy conference
in February 2017, part of national agenda to discuss health reform issues
VA Health Services Research &
Development, merit grant review panel –
invited to serve as grant reviewer for mental health proposals (March 2015 and
September 2016)
Interventions to Improve
Pharmacological Adherence among Patients with Psychotic-Spectrum Disorders,
Bipolar Disorder, and Posttraumatic Stress Disorder,
invited member (2015 – 2016): VA expert task force to evalulate
state of current clinical evidence to treat bipolar disorder and other serious
mental health conditions.
Women Veterans’ Perceptions of the
Affordable Care Act and Medicaid Expansion Restrictions
– site PI, Operations project from VA
Office of Women’s Health (2014)
Evaluation of a Short Pharmacy
Assessment for Adherence to Post-Discharge High-Risk Medications –
PI, unfunded Scott & White study (2012-2013).
Chair - IRB committee, Central Texas
Veterans Health Care System (2012 – 2017)
Research Grant Program (RGP) review committee,
Scott & White Healthcare, member (2011 – 2018)
Coordinator, VERDICT Research Forum (2007
– 2010): organized and led a weekly research seminar of internal investigators
and invited guest speakers.
Consultant, health services research
design and methods (2007 – 2010), several Practice Based Research Networks: StarNet (primary care
clinics), South Texas Psychiatry (community psychiatrists), Veterans Affairs
mental health (VA providers), VA Women’s Research Network.
Conference
presentations
(as lead author / presenter only):
April 2018: Health Care System Research
Network annual meeting (Minneapolis) – Factors Affecting Time between Symptom Onset
and Emergency Department Arrival in Stroke Patients (poster)
October 2017: ID Week (San Diego)
– 1) Lack
of Association Between Surface and Flourescent Marker Score (poster); 2) Does Pulsed Xenon Disinfection Add Additional
Value to Manual Cleaning? (poster)
July 2017: VA National Health Services
Research & Development Conference (Washington DC) – A
Multisite Implementation Trial of Portable Pulsed Xenon Ultraviolet Ray
Technology to Reduce Hospital Associated Infections (oral presentation)
August 2016: Mental Health Services
Research (NIMH) annual meeting (Bethesda, MD) – 1) Differences in
Depression Treatment for Diverse Patient Populations within the Mental Health
Research Network (workshop); 2) Partnering
with the Mental Health Research Network (symposium)
May 2016: International Society for
Pharmacoeconomics and Outcomes Research annual meeting (Washington DC) – A Framework for Measuring Multiple
Medication Adherence (workshop and forum)
April 2016: Health Care System Research
Network annual meeting (Atlanta) – 1) A
Depression Care Management Project to Improve Treatment Coordination and
Outcomes in Patients with Comorbid Conditions (poster); 2) Multiple Chronic
Conditions Associated with Hip Fracture Outcomes among Males (oral
presentation)
July 2015: VA National Health Services
Research & Development Conference (Philadelphia) – 1) Psychotropic Pharmacotherapy associated with QT Prolongation among
Veterans with Posttraumatic Stress Disorder (poster); 2) Using an Innovative Pulsed Xenon Ultraviolet
Ray Technology and Other Interventions to Reduce Hospital Associated Infections
(poster)
March 2015: Health Maintenance
Organization Research Network annual meeting (Long Beach) – 1) Interventions to Reduce Hospital Associated
Infections: Comparative Efforts at One HMORN Site and a Local Veterans Affairs
Facility (oral presentation); 2) A
Pharmacy Counseling and Post-Discharge Intervention to Improve Initial
Adherence for High-Risk Medications (poster)
May 2014: International Society for
Pharmacoeconomics and Outcomes Research annual meeting (Montreal) – A Framework for Conducting Initial
Medication Adherence Research (workshop and forum)
April 2014: Health Maintenance
Organization Research Network annual meeting (Phoenix) – Comparison of Antipsychotic Polypharmacy Trends Among Schizophrenia
Patients Across Multiple Healthcare Systems (poster – award finalist)
May 2013: International Society for
Pharmacoeconomics and Outcomes Research annual meeting (New Orleans) – Frequency and effect sizes of risk factors
associated with initial adherence (poster); also, presentation to ISPOR
Board of Directors concerning ongoing working group projects.
April
2013: Health Maintenance Organization Research Network annual meeting (San
Francisco) – Ethnicity and Factors
Associated with Medication Adherence in a Post-Discharge Medical Aid Program (poster)
July
2012: VA National Health Services Research & Development Conference (National
Harbor) – Longitudinal Medication
Adherence Instability and the Risk of Psychiatric Admission in Veterans with
Schizophrenia (poster)
April
2012: 3rd Biennial Schizophrenia International Research Society Conference (Florence,
Italy) – 1) Validating a New Measure of Longitudinal
Medication Adherence Instability and the Risk of Psychiatric Admission in Patients
with Schizophrenia (poster); 2) The
Impact of Cultural Competency on Reducing Ethnic Disparities in Psychiatric
Diagnosis: A Regional Variation Analysis (poster)
May
2011: International Society for Pharmacoeconomics and Outcomes Research
(Baltimore) – A Systematic Literature
Review of Behavioral Risk Factors Associated with Initial Medication Adherence (poster)
April
2011: International Conference of Schizophrenia Research (Colorado Springs) – Surgical Needs and Rates of Common
Procedures in Patients with Serious Mental Illness (oral presentation)
March
2011: HMO Research Network annual meeting (Boston) – Outcomes of Cardiovascular Events in Two Systems of Care (poster)
March
2011: International Workshop on Costs and Assessment in Psychiatry, Mental
Health Policy and Economics (Venice, Italy) – 1) Cost-Benefit Effects of Pharmacy Benefit Policies in Patients with
Schizophrenia (oral presentation); 2) moderated panel on costs of chronic
medical comorbidities
February
2011: VA National Health Services Research & Development Conference (Baltimore)
– Medication Adherence as a Measure of
Comparative Effectiveness in Older Patients with New-Onset Epilepsy (poster)
June
2010: Academy Health Annual Research Meeting (Boston, MA) – 1) Cost-Related Medication Adherence and
Patients’ Experience with the Chronic Care Model (oral presentation - Best
Abstract, Quality & Efficiency theme; 2) OEF-OIF
Post-Deployment Health Care Needs in Community-based Primary Care Clinics
(poster).
April
2010: VA National Health Services Research & Development Mental Health Conference
(
November
2009: National Association of Primary Care Research Group Annual Meeting (
June
2009: Academy Health Annual Research Meeting (
June
2009: Critical Research Issues in Latino Mental Health Conference (
March
2009: International Conference of Schizophrenia Research (
February
2009: VA National Health Services Research & Development Conference (Baltimore)
– 1) A Cost-Benefit Analysis of Higher
Medication Copayments in Veterans with Schizophrenia (oral presentation,
plenary session); 2) Diabetes and
Medication Adherence: Understanding the Association between Perceived Drug
Costs and Dimensions of the Therapeutic Alliance (oral presentation); 3) Veterans with Serious Mental Illness
Undergoing Surgical Procedures: Prevalence Rates of Preoperative Medical
Comorbidities (poster).
October
2008: American Psychiatric Association 60th Institute on Psychiatric
Services (Chicago) – Addressing Barriers to Effective Drug
Treatment in Public Mental Health (symposium).
May
2008: International Society for Pharmacoeconomics and Outcomes Research (Toronto)
– 1) Medication Adherence, Ethnicity, and
the Influence of Multiple Psychosocial and Financial Barriers (poster); 2) Ethnicity and the Impact of Higher
Medication Copayments among Veterans with Schizophrenia (poster – received
Best New Investigator top award); 3) The Cost-Offset
Effect of a Copayment Increase among Veterans with Schizophrenia (poster).
March
2008: Critical Research Issues in Latino Mental Health Conference (
February
2008: VA National Health Services Research & Development Conference (Baltimore)
– 1) Medication Adherence, Ethnicity, and
the Influence of Multiple Psychosocial and Financial Barriers in Veterans with
Bipolar Disorder (oral presentation); 2) Cardiovascular Disease in Type-2 Diabetes: Using the UKPDS Methodology
to Determine Attributable Risk Variance Across 20 Community Clinics (poster);
3) Patient Characteristics Affecting
Perceived Access to Medical and Psychiatric Care in Veterans with Bipolar Disorder
(poster).
June
2007: Seventh International Conference on Bipolar Disorder (Pittsburgh) – 1) Self-reported
Access to Medical and Psychiatric Care in Patients with Bipolar Disorder (oral presentation); 2) Therapeutic Alliance Perceptions and
Medication Adherence in Patients with Bipolar Disorder (poster).
March
2007: International Conference of Schizophrenia Research (
February
2006: VA National Health Services Research & Development Conference
(Washington DC) – 1) Ethnicity,
Perceptions of Therapeutic Alliance, and Adherence in Patients with Bipolar
Disorder (oral presentation); 2) Ethnicity
and the Impact of Higher Medication Copayments among Veterans with
Schizophrenia (poster); 3) The Role
of Comorbid Psychiatric Conditions on Health Status in Veterans with Epilepsy (poster).
April
2005: International Conference of Schizophrenia Research (
February
2005: VA National Health Services Research & Development Conference (
June
2004: Academy Health Conference (San Diego) – 1) Atypical Antipsychotics and
Schizophrenia with Comorbid Substance Abuse; 2) Efforts to Recruit Patients with
Schizophrenia into Randomized Research Studies (posters).
May
2004: American Psychiatric Association conference (
February
2003: VA National Health Services Research & Development Conference
(Washington DC) – 1) The Role of Ethnicity in the Diagnosis of Veterans with Serious Mental Illness
(oral presentation); 2) Aging and
Utilization Patterns among Veterans with Mental Illnesses (poster).
June
2002: Academy Health Conference (
April
2002: National
February
2002: VA National Health Services Research & Development Conference (
September
2001:
February
2001: VA National Health Services Research & Development Conference (
June
2000: Academy Health Conference (
Ad-hoc Journal Reviewer (over 225 reviews total):
In addition
to my current associate editor and board positions, I have contributed mansucript
reviews to about 40 health services and clinical journals, notably: American Journal of Managed Care, American Journal of Preventive
Medicine, American Journal of Public Health, Bipolar Disorder, BMC Health
Services Research, British Medical Journal, Comprehensive Psychiatry, Diabetes
Care, Journal of Affective Disorders, Journal of Healthcare for Poor and
Underserved, Journal of General Internal Medicine, Medical Care, Patient
Education and Counseling, Pharmocoepidemiology and Drug Safety, Psychiatric
Services, Schizophrenia Bulletin, Value in Health.
Scholarships,
Fellowships and Awards:
Ø Best
Abstract for Mental Health theme, HMO Research Conference 2014 - Antipsychotic
Polypharmacy Trends Among Schizophrenia Patients Across Multiple Healthcare
Systems.
Ø Best
Abstract for Quality & Efficiency: Improving Processes of Care theme,
Academy Health 2009 - Cost-Related Medication Adherence and Patients’
Experience with the Chronic Care Model.
Ø Best
New Investigator poster, ISPOR 2008 - Ethnicity and the Impact of Higher
Medication Copayments among Veterans with Schizophrenia.
Ø Agency for Health Care Policy and
Research (ACHPR) Fellowship – National Service Research Award,
University of Michigan, 1998-2000.
Ø Alumni Scholarship
– MHA program,
Ø First Interstate Scholarship
/ Dean’s List / Los Angeles Philanthropic Society Scholarship –
Ø Scholar-Athlete Award Finalist
–
Ø Most Valuable Player,
Most Inspirational – Intercollegiate
tennis: Occidental College, All-League
First Team – SCIAC league, 1985-1987.
Professional
Membership and Activities:
¨
AMSUS,
The Society of Federal Health Professionals, member (2019 –
present)
¨
Schizophrenia
International Research Society, member (2012 – present)
¨
American
Society of Hispanic Psychiatry, member (2008 – present)
¨
Academy
of Health Services Research, member (2002 – present)
¨
International
Society for Pharmacoeconomics & Outcomes Research
(ISPOR), member (2005 – present)
¨
Leadership
Committee -- MHA Program, University of Washington (1996
– 1998)
Peer-elected as Co-facilitator of the student run student organization. Full responsibility for overseeing and coordinating various sub-committees including budget and fundraising, orientation, graduation functions, student and professional mentor activities, and academic seminars. Also assisted with curriculum changes and admissions.
¨
Assisted in
developing the itinerary for a two-week comparative study experience of the
Norwegian healthcare system, September 1997. Included, among others, were
visits to the National Health Ministry, a for-profit hospital, a rural health
system, and an occupational health program. Helped draft funding proposal and
solicited financial support from the